Rocket Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 2.1M | 0 | 0 | 0 | 0 | 0 | 0 | 2.3M |
| Gross Profit | -2.1M | 0 | 0 | 0 | 0 | 0 | 0 | -2.3M |
| R&D Expenses | 31.5M | 29.3M | 34.1M | 42.7M | 35.9M | 37.4M | 42.3M | 44.8M |
| Operating Expenses | 46.4M | 44.0M | 52.2M | 71.1M | 64.4M | 62.7M | 69.4M | 71.4M |
| Operating Income | -48.5M | -44.0M | -52.2M | -71.1M | -64.4M | -62.7M | -69.4M | -73.7M |
| Other Income / Gains | 917K | 1.4M | 1.9M | 2.2M | 3.1M | 2.4M | 2.7M | 4.1M |
| Net Income | -47.6M | -42.5M | -50.3M | -68.9M | -61.3M | -60.3M | -66.7M | -69.6M |
| EPS (Diluted) | -0.42 | -0.38 | -0.45 | -0.62 | -0.56 | -0.62 | -0.71 | -0.74 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 17.1M | 14.7M | 18.4M | 25.0M | 28.4M | 25.3M | 27.1M | 27.4M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -786K |
| Selling General And Administrative Expenses | 17.1M | 14.7M | 18.4M | 25.0M | 28.4M | 25.3M | 27.1M | 26.6M |
| Other Expenses | -2.1M | -68K | -172K | 3.5M | 0 | 0 | 0 | 0 |
| Cost And Expenses | 48.5M | 44.0M | 52.2M | 71.1M | 64.4M | 62.7M | 69.4M | 73.7M |
| Interest Income | 1.5M | 6.2M | 2.4M | 2.7M | 3.5M | 2.8M | 3.2M | 4.5M |
| Interest Expense | 473K | 3.3M | 473K | 473K | 472K | 473K | 471K | 471K |
| Depreciation And Amortization | 2.1M | 2.2M | 3.2M | 2.6M | 3.0M | 2.4M | 2.4M | 2.3M |
| Ebitda | -45.0M | -37.0M | -46.6M | -65.9M | -57.9M | -57.5M | -63.9M | -66.8M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -47.6M | -42.5M | -50.3M | -68.9M | -61.3M | -60.3M | -66.7M | -69.6M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.42 | -0.38 | -0.45 | -0.62 | -0.56 | -0.62 | -0.71 | -0.74 |
| Weighted Average Shs Out | 112.1M | 111.1M | 111.6M | 111.0M | 110.1M | 97.5M | 94.2M | 93.7M |
| Weighted Average Shs Out Dil | 112.1M | 111.1M | 111.6M | 111.0M | 110.1M | 97.5M | 94.2M | 93.7M |